Skip to main content
. 2007 Mar 7;93(9):1051–1055. doi: 10.1136/hrt.2006.100180

Table 1 Demographic data of the study patients.

Patients treated with methadone Patients treated with buprenorphine p Value
n 407 43 ––
Sex (F:M) 107:300 9:34 0.4569
Mean (SD) age (years) 41.3 (8.3) 38.0 (7.6) 0.0145
Treatment period (years) (median (10th and 90th percentile)) 7 (0.5;20) 1 (0.02;4) <0.0001
Methadone dose (mg) (median (10th and 90th percentile)) 100 (50;235) –– ––
Buprenorphine dose (mg) (mean (10th and 90th percentile)) –– 5.4 (0.6;12) ––
Patients with cocaine use past week 76 (18.7%) 5 (10.6%) 0.2528
Patients with illicit opioid use past week 121 (29.7%) 16 (34.0%) 0.3108
Patients with cannabis use past week 243 (59.7%) 19 (40.4 %) 0.0497
Patients with illicit benzodiazepine use 88 (21.6%) 5 (10.7%) 0.1238